BioInformant

Your Global Leader in Stem Cell Market Research

Home » Cord Blood » Page 2

Cord Blood

Because cord blood present within a newborn’s umbilical is rich with stem cells, it can be collected and stored for future medical use.

Cryo-Cell Enters Exclusive Agreement for Duke University’s Cord Blood and Tissue Assets

By Leave a Comment

Cryo-Cell International, Inc. (symbol: CCEL), the world’s first private cord blood bank to separate and store stem cells, has entered into a collaborative license agreement with Duke University. The agreement grants Cryo-Cell the rights to proprietary processes and regulatory data related to cord blood and cord tissue developed at Duke.

MIAMI, Feb. 26, 2021 — Cryo-Cell plans to explore, test, and administer these treatments to patients with conditions for which there are limited FDA approved therapies, including cerebral palsy, autism, multiple sclerosis and COVID-19. [Read more…]

Alternate Ocean Offers to Acquire Largest Cord Blood Bank in China (GCBC) for $5/Share

By Leave a Comment

HONG KONG, March 2, 2021 — On March 2, 2021, Global Cord Blood Corporation (GCBC) announced that it received a non-binding proposal letter from Alternate Ocean Investment Company Limited (“Alternate Ocean”), a wholly-owned subsidiary of Haitong International Securities Group Limited.

The proposal letter offers for Alternate Ocean, acting on behalf of certain funds and entities that it manages or advises, to acquire all of the outstanding ordinary shares of GCBC for US$5.00 per ordinary share in cash. [Read more…]

ReeLabs: Cord Blood Banking in India (Population 1.4 Billion)

By Leave a Comment

ReeLabs is a leading cord blood bank in India. Cord blood banking in this region is of monumental importance, because the country has an astounding population of 1.4 billion. This represents an incredible 18% of the global population.

Meaning, one-out-of-every-five people on this planet lives in India and the country is now head-to-head with China as the world’s most populous country.

India’s population growth is fueled by a birth rate (19 births/1,000 population) that substantially exceeds its death rate (7.3 deaths/1,000 population).

If you’re involved with cord blood banking, you need to understand the important of this particular market and the trends emerging within it.

In this interview with Dr. Abhijit Bopardikar, Director of ReeLabs, he explains the rise of cord blood banking within India and discusses the importance of pairing stem cell therapy and research applications with stem cell storage services.

[Read more…]

Cord Blood Industry Consolidation Escalates in 2021

By 2 Comments

The global cord blood industry experienced strong growth from the early 1990’s through the late 2000’s, during which time more than 450 cord blood banking companies emerged worldwide. Approximately half of those companies owned their own labs, while the others were marketing entities or sub-contractors of storage space.

Starting about ten years ago, the market suddenly changed course. It entered a period of aggressive consolidation, cutting the global number of cord blood banks by approximately half.

Over the past decade, the cord blood industry has witnessed substantial consolidation, particularly within the United States, Europe, Asia, and Latin America. [Read more…]

Market for cord blood and perinatal tissue in 2021

By Leave a Comment

Over the past 30 years, cord blood and cord tissue have gained popularity and commercial traction due to the valuable stem cells they contain. According to ClinicalTrials.gov, there are approximately 1,300 clinical trials evaluating the use of cord blood and tissue-derived cells. These studies typically leverage unmanipulated whole cord blood (total nucleated cells/TNC), mononuclear cells (MNC), or cord blood-derived mesenchymal stem cells (MSCs). [Read more…]

BioInformant's World-Class Clients